M&A Deal Summary

SK Capital Partners Acquires Woodstock

On March 31, 2021, private equity firm SK Capital Partners acquired life science company Woodstock from Catalent

Acquisition Highlights
  • This is SK Capital Partners’ 4th transaction in the Life Science sector.
  • This is SK Capital Partners’ 19th transaction in the United States.
  • This is SK Capital Partners’ 1st transaction in Illinois.

M&A Deal Summary
Date 2021-03-31
Target Woodstock
Sector Life Science
Buyer(s) SK Capital Partners
Sellers(s) Catalent
Deal Type Divestiture

Target

Woodstock

Woodstock, Illinois, United States
Woodstock is an operator of BFS sterile contract development and manufacturing organization (CDMO) that operates out of a single site in Woodstock, Illinois, focusing on complex clinical to commercial-stage formulation and manufacturing. The Company supports a global, blue-chip customer base with a broad array of products that leverage its BFS sterile manufacturing capabilities and formulation competency in complex chemistries, including small molecule, biologics, macromolecules, and potent compounds. Woodstock is based in Woodstock, Illinois.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

SK Capital Partners

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2007
PE ASSETS 4.9B USD
Size Large
Type Sector Agnostic
DESCRIPTION

SK Capital Partners is a private investor in mature and middle-market companies located throughout North America. SK Capital focuses on companies with opportunities for substantial business improvement and strong growth prospects. The Firm looks to invest $100 to $200 million of equity in transactions valued up to $500 million. Prospective businesses typically generate $50 to $500 million in revenues and at least $100 million in EBITDA. Areas of interest include specialty materials, chemicals and healthcare. The Firm will consider a variety of transaction situations, including buyouts, recapitalizations, growth equity financings, and corporate carve-outs. SK Capital Partners was spun out of Arsenal Capital Partners and became independent in 2007. SK Capital Partners is based in New York City.

DEAL STATS #
Overall 28 of 41
Sector (Life Science) 4 of 5
Type (Divestiture) 12 of 16
State (Illinois) 1 of 1
Country (United States) 19 of 27
Year (2021) 3 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-11 Lacerta Group

Mansfield, Massachusetts, United States

Lacerta Group is a provider of thermoformed packaging solutions. The Company has built its reputation based on product integrity, excellent customer service, and above all, speed to market. Lacerta offers a comprehensive product portfolio and in-house design capabilities, with a customer-centric business model focused on tailored solutions for food processors and supermarkets. The Company’s fully integrated manufacturing platform includes capabilities across the product lifecycle in design & engineering, prototyping, mold-making & tooling, thermoforming, extrusion, and printing. Lacerta Group was founded in 1993 and is based in Mansfield, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-27 Canlak

Daveluyville, Quebec, Canada

Canlak is a manufacturer of specialty chemicals. Canlak was founded in 1981 and is based in Daveluyville, Quebec.

Buy -

Seller(S) 1

SELLER

Catalent

Somerset, New Jersey, United States
Category Company
Founded 2007
Sector Life Science
Revenue 4.3B USD (2023)
DESCRIPTION

Catalent is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent was founded in 2007 and is based in Somerset, New Jersey.

DEAL STATS #
Overall 2 of 3
Sector (Life Science) 2 of 3
Type (Divestiture) 2 of 3
State (Illinois) 1 of 1
Country (United States) 2 of 3
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-23 Delphi Genetics SA

Gosselies, Belgium

Delphi Genetics SA is a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization (CDMO). Delphi Genetics was founded in 2001 and is based in Gosselies, Belgium.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-30 Bettera Brands

Plano, Texas, United States

Bettera Brands operates as a holding company for Bettera Wellness, Nutravail, and Hillside, which focus on using confection products as an alternative delivery systems for vitamins, minerals and supplements. Bettera Wellness is a manufacturer of branded and private label gummy vitamins and better-for-you gummy confection products. Bettera operates two fully integrated production facilities located in Indiana and California that are SQF Level 3 and CFR 111 certified for dietary supplements. Nutravail, operating from a CFR 111 facility in Chantilly, Virginia, is a leading developer and manufacturer of health and wellness food products that manufactures proprietary soft chew delivery systems with its low-temperature processing technology. Hillside is a manufacturer of organic, sugar-free, and branded confection products (through its GoOrganic brand), as well as incorporating nutraceutical ingredients into lozenge delivery systems. Bettera Brands was formed in 1898 and is based in Plano, Texas.

Buy $1.0B
Mergr

Product

Company

Legal